使用机器学习对胺衍生物作为丁氧化酶抑制剂的定量结构-活性关系研究
Xiaoda Yang1, Hongshun Qiu1, Yuxiang Zhang1
1College of Computer Science and Technology, Qingdao University, Qingdao, China.
Frontiers in pharmacology
|July 17, 2023
概括
这项研究预测了胺衍生物.
科学领域:
- 药用化学 医学化学
- 计算化学的计算化学
- 药物发现 药物发现 药物发现
背景情况:
- 丁氧化酶 (XO) 是 purin代谢中的关键酶,与痛风和其他疾病有关.
- 胺衍生物是一种具有潜在治疗应用的化合物.
- 了解这些衍生物的结构-活性关系对于药物开发至关重要.
研究的目的:
- 预测胺衍生物对丁氧化酶 (XO) 的抑制作用.
- 开发和比较定量结构-活性关系 (QSAR) 模型来预测抑制活性.
- 为此类化合物确定最有效的建模方法.
主要方法:
- 使用了定量结构-活动关系 (QSAR) 建模.
- 线性建模使用启发式方法 (HM) 进行描述器选择.
- 非线性建模涉及XGBoost用于描述器选择和各种支持向量回归 (SVR) 模型 (RBF,多项式,线性,混合内核) 和随机森林 (RF).
主要成果:
- 混合内核SVR (MIX-SVR) 模型表现出最好的性能.
- MIX-SVR结合了线性,RBF和多项式内核,增强了学习和概括.
- 交叉验证 (LOOCV) 证实了模型的稳定性,在训练和测试集上具有高R平方和低RMSE值.
结论:
- MIX-SVR建模方法对于预测胺基衍生物对丁氧化酶的抑制活性是有效的.
- 开发的QSAR模型为XO抑制的结构要求提供了宝贵的见解.
- 这项研究强调了计算方法在指导新型治疗药物的设计方面的潜力.
相关概念视频
Structure-Activity Relationships and Drug Design
777
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
777
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.1K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.1K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
608
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
608
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.1K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
1.1K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.3K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.3K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.9K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.9K


